News

ATKearney releases follow up discussion on ‘Winning with Digital’ study

BY Antoinette Alexander

NEW YORK — Retailers’ shift from traditional to digital marketing vehicles stands to threaten the traditional forms of collaboration between retailers and their consumer packaged goods partners and requires even tighter collaboration between the two parties in order to succeed. That’s according to ATKearney’s newly released “Implications of the ‘Winning with Digital’ Study.”

To shed light on retailers’ shift from traditional to digital marketing vehicles, the National Association of Chain Drug Stores asked ATKearney to conduct a study. That study, dubbed “Winning with Digital,” was unveiled during the recent NACDS Total Store Expo in Boston. However, as ATKearney conducted that study it came to believe that digital transformation has far-reaching implications worthy of further discussion. Enter the follow-up “thought paper” called, “Implications of the ‘Winning with Digital’ Study.”

In the follow-up discussion, ATKearney suggests that, in order to collaborate effectively in digital marketing that moves product in the physical world, retailers and manufacturer partners must align on five key points:

  • Target segments;
  • Explicit parameters;
  • Ample offers;
  • Motivating content; and
  • Rapid test and learn.

“The majority of predominantly brick-and-mortar retailers still have large transformations ahead of them to exploit the opportunities available from digital techniques. Mindsets, organizations and processes will change as marketing approaches shift toward digital. Meanwhile, CPGs can support their retail partners through this transformation,” the paper states.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

QS/1, Veridikal partner for reconciliation programs

BY Ryan Chavis

SPARTANBURG, S.C. — QS/1, a healthcare automation solutions provider, on Monday announced that it now offers Veridikal Intelligence and Veridikal’s Reconciliation program to the pharmacies it serves. The program includes pre- and post-editing, EDI support, 835 processing, forensic auditing and reconciliation. 
 
This type of program allows pharmacies to eliminate many errors before claims are processed, the company said, which increases payments and accelerates prescription delivery to customers.
 
“Pre- and post-edits service evaluates prescription claims for omissions, errors and compliance with industry standards and metrics,” said Revonda Spratt, QS/1 VP, operations. “This prevents the pharmacy from submitting a claim the insurance provider would reject due to missing or inaccurate information, and decreases the possibility of paying multiple submission charges on a single prescription.”
 
The Veridikal business edits program allow for additional analysis of claims before they are sent to a third party, helping to reduce the number of errors before the claim is processed to ensure revenue enhancements while also reducing the amount of time pharmacy employees spend on correcting claims that rejected.
 
“Business edit training and support are provided to all customers,” said Larry Lane, Veridikal SVP marketing. “The pharmacy staff also has the ability to access Veridikal University’s comprehensive training program designed to meet the staff’s schedule and apply for continuing education.” 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

FDA approves two new indications for Epaned

BY Ryan Chavis

DENVER — Silvergate Pharmaceuticals on Monday announced that the Food and Drug Administration approved Epaned (enalapril maleate Powder for oral solution) for the treatment of symptomatic heart failure, as well as the treatment of asymptomatic left ventricular dysfunction. The drug was previously approved to treat high blood pressure in patients older than one month of age. 
 
"Now with three indications, Epaned is available to help more patients who need the proven benefits of enalapril in an FDA-approved powder for oral solution, thereby ensuring that they are receiving a medicine that meets the highest quality standards," said Frank Segrave, president and CEO, Silvergate Pharmaceuticals.
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?